Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (876)	2/5/1999 6:50:00 PM
From: erin4	Read Replies (2) \| Respond to of 1837

I am a physician and I was talking with an American Home Products pharmaceutical rep the other day. He knew that Duramed is close to getting approval for Cenestin to compete against their Premarin. He sounded like AHP has briefed all their reps about this possibility and he was fast to point out that Cenestin is not a generic Premarin but "a separately branded product similar to but not premarin". This will probably be AHP's marketing approach to keep as much of the market for themselves. Duramed can point out that Cenestin is made from yams while Premarin is made from horse urine. Also that Cenestin is a purer product.